Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
Clinical trial NCT02501018 · COMPLETED
Trial details
- NCT number
- NCT02501018
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2022-05-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.